Migraine can affect all aspects of someone's life. Learn more about how it has impacted 17-year old Katharyn and her mom, Lori, who also suffers, and what they are doing to help others learn about the disorder.
Biohaven Pharmaceuticals is studying an investigational drug to potentially treat migraines in children and teens. If your child is between 6 and 17 years of age and has at least a 6-month history of migraine, they may qualify. Learn more about our pediatric migraine study.